Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
5/31/2025
Recent Official and Executive Moves
5/31/2025
China Approves First Homegrown Nine-Valent HPV Vaccine
5/31/2025
Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...
5/31/2025
China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM
5/31/2025
Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies
5/31/2025
Hansoh Receives NMPA Approval for Clinical Trials of Three Innovative ...
5/31/2025
China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...
5/31/2025
NMPA Issues New Regulations on Experimental Research of Narcotic and P...
5/31/2025
NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...
5/31/2025
CSPC Eyes $5B in Licensing Deals for EGFR-ADC and Innovative Therapies
5/31/2025
Astellas Enters Exclusive License Agreement with Evopoint Biosciences ...
5/31/2025
Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...
5/31/2025
Former CFDA Commissioner Bi Jingquan Under Investigation for Serious ...
5/29/2025
First Patient Dosed in YK012 Trial -The World's First TCE Therapy for ...
5/29/2025
CDE Solicits Comments on Draft Technical Considerations for NMR Studi...
5/29/2025
CDE Issues Guideline on Production Site Change Research for Licensed B...
5/29/2025
CDE Launches “Starlight Plan” to Encourage Pediatric Antitumor Drug ...
5/29/2025
CDE Issues Guideline on Safety Assessment and Reporting in Pediatric D...
5/29/2025
AusperBio Secures $50M in Series B+ Financing
5/29/2025
Rona Unveils Promising Preclinical Data for Annual RNAi Therapy
5/29/2025
Livzon Acquires Majority Stake in Vietnam's Imexpharm for $221 Million
5/29/2025
China Grants Conditional Approval to Hengrui's Famitinib
5/29/2025
China Approves Zelgen's Gecacitinib
5/29/2025
China Grants Conditional Approval to Two HER2-Targeted Therapies for A...
5/29/2025
Kanion's Generic Sumatriptan/Naproxen Gains Approval in China
5/29/2025
China Approves Two New CDK4/6 Inhibitors for Advanced Breast Cancer
5/29/2025
Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...
5/29/2025
Kelun-Biotech Initiates Phase 1 Trial for SKB571, a Bispecific ADC Tar...
5/29/2025
Novartis Secures NMPA Approval for Beovu for DME in China
5/29/2025
Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED
Page:
1
/
50
Total number of articles:
1490
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit